Kansas Bioscience Authority

Advanced Animal Diagnostics, Inc. focuses on the research, development, and commercialization of on-farm diagnostic tools aimed at the early detection of subclinical mastitis in dairy cows. Based in Durham, North Carolina, the company offers products such as the QScout Farm Lab, an analyzer system that identifies infections in dairy cows before symptoms manifest, and the QScout Milk Leukocyte Differential rapid test, which analyzes milk to detect and differentiate white blood cells indicative of mastitis. Additionally, Advanced Animal Diagnostics provides solutions like QuickSmear, a rapid differential slide that aids in animal research, and the SCC+ System for early mastitis detection. These diagnostic tools are designed to enhance animal health management, benefiting veterinarians and livestock producers by enabling timely detection of infections and supporting informed treatment decisions. Founded in 2001, the company aims to improve the overall health and productivity of production animals.

Flow Forward Medical is a company focused on developing vascular access solutions to enhance post-surgery success rates. Its primary product, the Arteriovenous Fistula Eligibility (AFE) System, is a small, temporary external blood pump engineered to promote flow-mediated dilation of veins. This innovation aims to increase the eligibility of patients for arteriovenous fistula (AVF) procedures, which are critical for hemodialysis patients. By improving the establishment of reliable AVFs, Flow Forward Medical seeks to reduce both morbidity and mortality among these patients, while also lowering overall healthcare costs. Founded in 2014 by Frank Nicholas Franano, the company is based in Olathe, Kansas.

Innara Health, Inc. specializes in developing neonatal care technologies aimed at improving the health and development outcomes for preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device that supports the development of non-nutritive sucking skills in newborns, which is crucial for feeding. This system assists caregivers in neonatal and pediatric intensive care units by providing insights into effective treatment strategies for infants facing feeding challenges. Founded in 2006 and based in Olathe, Kansas, Innara Health was previously known as KCBioMedix, Inc. until it rebranded in 2013. The company’s innovations are focused on enhancing the quality of life for infants and their families, as well as improving overall feeding outcomes in hospital settings.

Artio Medical, Inc. specializes in the development and commercialization of catheter-based medical devices aimed at treating cardiovascular diseases. The company offers a range of products, including Solus Gold and Solus Flex, which are embolization devices designed for precise and immediate vessel occlusion. Additionally, Artio Medical provides Aneura and Endura, which utilize a combination of coils and accessory balloons to effectively occlude saccular peripheral and cerebral aneurysms respectively. Founded in 2011, the company is headquartered in Prairie Village, Kansas, and operates as a subsidiary of Novita Therapeutics, LLC. Artio Medical's innovative medical devices enhance the safety, speed, and effectiveness of vascular occlusion procedures for healthcare professionals.

Advanced Animal Diagnostics, Inc. focuses on the research, development, and commercialization of on-farm diagnostic tools aimed at the early detection of subclinical mastitis in dairy cows. Based in Durham, North Carolina, the company offers products such as the QScout Farm Lab, an analyzer system that identifies infections in dairy cows before symptoms manifest, and the QScout Milk Leukocyte Differential rapid test, which analyzes milk to detect and differentiate white blood cells indicative of mastitis. Additionally, Advanced Animal Diagnostics provides solutions like QuickSmear, a rapid differential slide that aids in animal research, and the SCC+ System for early mastitis detection. These diagnostic tools are designed to enhance animal health management, benefiting veterinarians and livestock producers by enabling timely detection of infections and supporting informed treatment decisions. Founded in 2001, the company aims to improve the overall health and productivity of production animals.

Health Outcomes Sciences is dedicated to providing innovative IT solutions that improve the quality of healthcare delivery. We focus on translating the latest advances in clinical research into decision-support products and services for physicians and their patients, healthcare organizations, and other medical software developers. Their solutions empower users to see complex relationships between clinical variables—such as comorbidities, sociodemographic attributes, biochemical markers, and genomic determinants—and patient outcomes. Better understanding of these relationships allows patient care to be individualized in ways that previously could only be imagined. Their interdisciplinary team of physicians, outcomes researchers, and information technology experts pay special attention to creating user interfaces that are both intuitive and responsive and that readily integrate into the workflow of the researchers who develop risk models and the clinicians who use them.

Flow Forward Medical is a company focused on developing vascular access solutions to enhance post-surgery success rates. Its primary product, the Arteriovenous Fistula Eligibility (AFE) System, is a small, temporary external blood pump engineered to promote flow-mediated dilation of veins. This innovation aims to increase the eligibility of patients for arteriovenous fistula (AVF) procedures, which are critical for hemodialysis patients. By improving the establishment of reliable AVFs, Flow Forward Medical seeks to reduce both morbidity and mortality among these patients, while also lowering overall healthcare costs. Founded in 2014 by Frank Nicholas Franano, the company is based in Olathe, Kansas.

Aratana Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for dogs and cats in the United States. Founded in 2010 and based in Leawood, Kansas, the company offers a range of products including NOCITA for post-operative pain management in dogs, ENTYCE for appetite stimulation, and GALLIPRANT for osteoarthritis pain and inflammation. Additionally, it is advancing several therapeutic candidates, such as a bupivacaine liposome injectable suspension for cats, a formulation of capromorelin for appetite stimulation in cats, and treatments for atopic dermatitis and feline herpes virus. Aratana collaborates with other organizations, including Elanco Animal Health and Pacira Pharmaceuticals, to enhance its product development and commercialization efforts. The company aims to address unmet needs in companion animal healthcare by leveraging proprietary technologies and scientific advancements.

Aratana Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for dogs and cats in the United States. Founded in 2010 and based in Leawood, Kansas, the company offers a range of products including NOCITA for post-operative pain management in dogs, ENTYCE for appetite stimulation, and GALLIPRANT for osteoarthritis pain and inflammation. Additionally, it is advancing several therapeutic candidates, such as a bupivacaine liposome injectable suspension for cats, a formulation of capromorelin for appetite stimulation in cats, and treatments for atopic dermatitis and feline herpes virus. Aratana collaborates with other organizations, including Elanco Animal Health and Pacira Pharmaceuticals, to enhance its product development and commercialization efforts. The company aims to address unmet needs in companion animal healthcare by leveraging proprietary technologies and scientific advancements.

Innara Health, Inc. specializes in developing neonatal care technologies aimed at improving the health and development outcomes for preterm and full-term infants, as well as children with developmental needs. The company is best known for its NTrainer System, a medical device that supports the development of non-nutritive sucking skills in newborns, which is crucial for feeding. This system assists caregivers in neonatal and pediatric intensive care units by providing insights into effective treatment strategies for infants facing feeding challenges. Founded in 2006 and based in Olathe, Kansas, Innara Health was previously known as KCBioMedix, Inc. until it rebranded in 2013. The company’s innovations are focused on enhancing the quality of life for infants and their families, as well as improving overall feeding outcomes in hospital settings.

Osteogenix is a therapeutic products company with novel products for the large and rapidly growing area of bone repair and bone growth. Osteogenix was founded in 2005 to clinically develop and commercialize the osteo-pharmacologic platform discovered and patented by Dr. Mundy and his associates. Osteogenix assembled an outstanding team of expert advisors, many of whom have been principal investigators in key orthobiologics trials.

IGXBio, Inc. is a biotechnology company focused on the development of advanced DNA immunotherapies specifically aimed at treating HIV infection. The company has created a proprietary DNA composition that synthetically mimics the virus, which helps to stimulate an immune response. This innovative approach aims to be less toxic than existing AIDS drug cocktails, potentially allowing healthcare providers to reduce the incidence of infections, particularly those related to HIV.

VasoGenix Pharmaceuticals, Inc., is developing intravenous (IV) and controlled release drug treatments for addressing Heart Failure ("HF") and other cardiac diseases in order to reduce the recurrence of these diseases and their resulting hospital and medical costs. VasoGenix is initially focusing on a major unmet critical need in Acute Decompensated Heart Failure ("ADHF"), when the symptoms of HF become severe enough to require hospitalization.